Búsqueda | Biblioteca Virtual en Salud

1.

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Hirschfield, Gideon M; Liu, Xiangdong; Xu, Chun; Lu, Yue; Xie, Gang; Lu, Yan; Gu, Xiangjun; Walker, Erin J; Jing, Kaiyan; Juran, Brian D; Mason, Andrew L; Myers, Robert P; Peltekian, Kevork M; Ghent, Cameron N; Coltescu, Catalina; Atkinson, Elizabeth J; Heathcote, E Jenny; Lazaridis, Konstantinos N; Amos, Christopher I; Siminovitch, Katherine A.

N Engl J Med ; 360(24): 2544-55, 2009 Jun 11.

Artículo en Inglés | MEDLINE | ID: mdl-19458352

2.

Blue-Print for Elimination of Hepatitis C Viral Infection: One Step Closer.

Peltekian, Kevork M.

Ann Hepatol ; 16(5): 696-698, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28809738

3.

Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centres.

Yoshida, Eric M; Swain, Mark Gordon; Tsien, Cynthia; Tam, Edward; Bailey, Robert James; Grbic, Dusanka; Hin Ko, Hin; Ramji, Alnoor; Hilzenrat, Nir; Elkhashab, Magdy; Kim, Euiseok; O'Brien, Meaghan; Amedeo Puglia, Marco; Peltekian, Kevork M.

Can Liver J ; 5(3): 372-387, 2022 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-36133904

4.

Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?

Peltekian, Kevork M; Bain, Vincent G; Lee, Samuel S; Sherman, Morris; Cooper, Curtis L; Yoshida, Eric M; Marotta, Paul J; Krajden, Mel; Balshaw, Robert; Deschênes, Marc.

Ann Hepatol ; 10(3): 260-9, 2011.

Artículo en Inglés | MEDLINE | ID: mdl-21677327

5.

HBV coinfection and in-hospital outcomes for COVID-19: a systematic review and meta-analysis.

Zhu, Julie H; Peltekian, Kevork M.

Can Liver J ; 4(1): 16-22, 2021.

Artículo en Inglés | MEDLINE | ID: mdl-35991468

6.

The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.

Davtyan, Tigran K; Hovsepyan, Marine P; Mkhitaryan, Levon M; Hakobyan, Gagik S; Brazil, Aiden; Barrett, Lisa; Hirsch, Geri; Peltekian, Kevork M; Grant, Michael D.

Immunol Cell Biol ; 87(6): 457-63, 2009.

Artículo en Inglés | MEDLINE | ID: mdl-19333248

7.

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

Almutairi, Fawaz; Peterson, Theresa C; Molinari, Michele; Walsh, Mark J; Alwayn, Ian; Peltekian, Kevork M.

Liver Transpl ; 15(5): 504-8, 2009 May.

Artículo en Inglés | MEDLINE | ID: mdl-19399742

8.

Cannabis and the liver: Things you wanted to know but were afraid to ask.

Zhu, Julie; Peltekian, Kevork M.

Can Liver J ; 2(3): 51-57, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-35990221

9.

Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study.

Yoshida, Eric M; Mason, Andrew; Peltekian, Kevork M; Shah, Hemant; Thiele, Sherri; Borrelli, Richard; Fischer, Aren.

CMAJ Open ; 6(4): E664-E670, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30578275

10.

Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

White, Colin P; Hirsch, Gerilynn; Patel, Sunil; Adams, Fatin; Peltekian, Kevork M.

Can J Gastroenterol ; 21(9): 589-95, 2007 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-17853954

11.

Poor prediction of the glomerular filtration rate using current formulas in de novo liver transplant patients.

Cantarovich, Marcelo; Yoshida, Eric M; Peltekian, Kevork M; Marotta, Paul J; Greig, Paul D; Kneteman, Norman M; Marleau, Denis; Barkun, Jeffrey.

Transplantation ; 82(3): 433-6, 2006 Aug 15.

Artículo en Inglés | MEDLINE | ID: mdl-16906045

12.

Canada needs viral hepatitis action plan.

Peltekian, Kevork M; Hirsch, Geri; Burgess, Carla.

CMAJ ; 183(15): 1751, 2011 Oct 18.

Artículo en Inglés | MEDLINE | ID: mdl-22007127

13.

Diabetes mellitis: risk factor for advanced liver disease.

Siddiqi, Ferhan; Carter, Lindsay; Peltekian, Kevork M.

CMAJ ; 183(5): 586, 2011 Mar 22.

Artículo en Inglés | MEDLINE | ID: mdl-21422147

14.

Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?

MacAulay, Jillian; Thompson, Kara; Kiberd, Bryce A; Barnes, David C; Peltekian, Kevork M.

Can J Gastroenterol ; 20(8): 521-6, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16955148

15.

Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Watt, Kymberly D S; Burak, Kelly; Deschênes, Marc; Lilly, Les; Marleau, Denis; Marotta, Paul; Mason, Andrew; Peltekian, Kevork M; Renner, Eberhard L; Yoshida, Eric M.

Can J Gastroenterol ; 20(11): 725-34, 2006 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-17111055

16.

Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.

Bazarah, Salem M; Ritenour, Rusty; Patel, Sunil T; Hirsch, Geri; Peltekian, Kevork M; Cruess, Alan F.

Ann Hepatol ; 5(3): 172-6, 2006.

Artículo en Inglés | MEDLINE | ID: mdl-17060876

17.

Colon cancer screening.

Peltekian, Kevork M.

CMAJ ; 174(7): 975; author reply 975-6, 2006 Mar 28.

Artículo en Inglés | MEDLINE | ID: mdl-16567759

18.

Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Sanyal, Chiranjeev; Ingram, Ethel Langille; Sketris, Ingrid S; Peltekian, Kevork M; Kirkland, Susan.

Can J Hosp Pharm ; 64(2): 131-40, 2011 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-22479042

19.

Improving access to transient elastography in Canada will need more than evidence-based guidelines and technical health assessment.

Peltekian, Kevork M.

Can J Gastroenterol Hepatol ; 29(7): 343-4, 2015 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-26466385

20.

Identifying HCV genotype 1 patients at risk of relapse.

Deschênes, Marc; Bain, Vincent G; Lee, Samuel S; Sherman, Morris; Cooper, Curtis L; Yoshida, Eric M; Marotta, Paul J; Krajden, Mel; Usaty, Christopher; Balshaw, Robert; Peltekian, Kevork M.

Eur J Gastroenterol Hepatol ; 22(5): 546-51, 2010 May.

Artículo en Inglés | MEDLINE | ID: mdl-20216320

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Blue-Print for Elimination of Hepatitis C Viral Infection: One Step Closer.

Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centres.

Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?

HBV coinfection and in-hospital outcomes for COVID-19: a systematic review and meta-analysis.

The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

Cannabis and the liver: Things you wanted to know but were afraid to ask.

Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study.

Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Poor prediction of the glomerular filtration rate using current formulas in de novo liver transplant patients.

Canada needs viral hepatitis action plan.

Diabetes mellitis: risk factor for advanced liver disease.

Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?

Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.

Colon cancer screening.

Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Improving access to transient elastography in Canada will need more than evidence-based guidelines and technical health assessment.

Identifying HCV genotype 1 patients at risk of relapse.